P55.9
Hemolytic disease of newborn, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Hemolytic disease of the newborn (HDN) is a condition that occurs when a baby's red blood cells are destroyed faster than they can be produced. When this imbalance happens, it can lead to anemia, jaundice, and in severe cases, other health complications. The ICD-10 code P55.9 refers to an unspecified form of this disease, meaning specific details about the cause are not provided. This condition is important to recognize early to ensure proper management and prevent severe health problems for the newborn.
Causes & Symptoms
Clinical Causes: Maternal-child blood group incompatibility, especially Rh or ABO mismatch Previous pregnancies with incompatibility leading to sensitization Presence of irregular antibodies in the mother's blood Certain infections during pregnancy that affect red blood cell survival
Key Symptoms: Jaundice (yellowing of the skin and eyes) Poor feeding and irritability Dark urine Swelling or edema due to fluid buildup Enlarged liver or spleen Anemia, leading to fatigue and pallor in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of hemolytic disease of the newborn involves a combination of blood tests and assessments, including: - Blood type testing of the mother and baby - Coombs test (direct antiglobulin test) to detect maternal antibodies attached to the baby's red blood cells - Complete blood count (CBC) to evaluate anemia - Bilirubin levels to assess jaundice severity - Imaging studies like ultrasound may be used to observe for complications if needed
Treatment Protocols: The management of HDN depends on the severity of the condition. Typical treatment options include: - Phototherapy to help break down excess bilirubin and reduce jaundice - Blood transfusions, if anemia is severe - Intravenous immunoglobulin (IVIG) in certain cases to reduce antibody effects - Monitoring and supportive care to maintain hydration and nutrition - In very severe cases, exchange transfusions may be performed to remove maternal antibodies and extricate damaged red blood cells Close medical supervision is essential to address any complications and ensure the health and safety of the newborn.
Clinical Advice & FAQs
Billing Guidance
Is P55.9 a billable ICD-10 code?
Yes, P55.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P55.9?
Clinical documentation must specify the nature of Hemolytic disease of newborn, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference